123 related articles for article (PubMed ID: 90920)
1. Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.
Terman DS; Buffaloe G; Mattioli C; Cook G; Tillquist R; Sullivan M; Ayus JC
Lancet; 1979 Oct; 2(8147):824-7. PubMed ID: 90920
[TBL] [Abstract][Full Text] [Related]
2. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide.
Palmer A; Cairns T; Dische F; Gluck G; Gjorstrup P; Parsons V; Welsh K; Taube D
Nephrol Dial Transplant; 1991; 6(8):536-42. PubMed ID: 1956551
[TBL] [Abstract][Full Text] [Related]
3. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
Kronbichler A; Brezina B; Quintana LF; Jayne DR
Autoimmun Rev; 2016 Jan; 15(1):38-49. PubMed ID: 26318215
[TBL] [Abstract][Full Text] [Related]
5. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
6. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
Yumura W; Suganuma S; Nitta K; Sano Y; Uchida K; Nihei H
Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy].
Welcker M; Helmke K
Immun Infekt; 1995 Aug; 23(4):140-1. PubMed ID: 7558119
[TBL] [Abstract][Full Text] [Related]
8. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
9. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption (IAS) for systemic lupus erythematosus.
Stummvoll GH
Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
[TBL] [Abstract][Full Text] [Related]
11. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report.
Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR
Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738
[TBL] [Abstract][Full Text] [Related]
12. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
Schneider M; Berning T; Waldendorf M; Glaser J; Gerlach U
J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
[TBL] [Abstract][Full Text] [Related]
13. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
14. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
Cavallo T; Graves K; Granholm NA
Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
Stummvoll G; Aringer M; Handisurya A; Derfler K
Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus glomerulonephritis in children.
Garin EH; Shulman ST; Donnelly WH; Richard GA
Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
[TBL] [Abstract][Full Text] [Related]
17. Different mode of circulating immune complexes and anti-ssDNA antibodies in sera of lepromatous leprosy and systemic lupus erythematosus.
Furukawa F; Yoshida H; Sekita K; Ozaki M; Imamura S; Hamashima Y
Lepr Rev; 1984 Sep; 55(3):291-9. PubMed ID: 6492990
[No Abstract] [Full Text] [Related]
18. Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants.
Cavallo T; Graves K; Granholm NA
Clin Exp Immunol; 1984 Jan; 55(1):67-73. PubMed ID: 6607142
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
20. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
Alper CA; Rosen FS
J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
